UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Clinical Guideline on Paget’s Disease of bone—A Guideline or a Review?

Journal of bone and mineral research, 2019-04, Vol.34 (4), p.577-578

Langdahl, BL

2019

Volltextzugriff (PDF)

SP0037 What To Do When A Fracture Occurs after 3 Years Treatment with An Oral Bisphosphonate?

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.10-10

Langdahl, B.

2016

Volltextzugriff (PDF)

Is There a Place for Bone Turnover Markers in the Management of Osteoporosis?

Journal of bone and mineral research, 2018-07, Vol.33 (7), p.1197-1198

Langdahl, BL

2018

Volltextzugriff (PDF)

The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial

Osteoporosis international, 2021, Vol.32 (1), p.185-191

2021

Volltextzugriff (PDF)

Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study

Osteoporosis international, 2022-06, Vol.33 (6), p.1323-1334

2022

Volltextzugriff (PDF)

A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk

The journal of clinical endocrinology and metabolism, 2014-04, Vol.99 (4), p.E729-E733

2014

Volltextzugriff (PDF)

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

Osteoporosis international, 2012-09, Vol.23 (9), p.2257-2276

2012

Volltextzugriff (PDF)

A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density

Osteoporosis international, 2023-11, Vol.34 (11), p.1893-1906

2023

Volltextzugriff (PDF)

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

Osteoporosis international, 2020-11, Vol.31 (11), p.2231-2241

2020

Volltextzugriff (PDF)

Romosozumab for the treatment of osteoporosis – a systematic review

Journal of endocrinological investigation, 2024-11

2024

Volltextzugriff (PDF)

Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials

Osteoporosis international, 2024-07, Vol.35 (7), p.1195-1204

2024

Volltextzugriff (PDF)

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

Osteoporosis international, 2009-12, Vol.20 (12), p.2095-2104

2009

Volltextzugriff (PDF)

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

Osteoporosis international, 2011-10, Vol.22 (10), p.2709-2719

2011

Volltextzugriff (PDF)

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study

Journal of bone and mineral research, 2012-11, Vol.27 (11), p.2251-2258

2012

Volltextzugriff (PDF)

Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis

Osteoporosis international, 2019-05, Vol.30 (5), p.995-1002

2019

Volltextzugriff (PDF)

Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study

Osteoporosis international, 2021-06, Vol.32 (6), p.1103-1115

2021

Volltextzugriff (PDF)

Socio-economic inequalities in fragility fracture incidence: a systematic review and meta-analysis of 61 observational studies

Osteoporosis international, 2021-12, Vol.32 (12), p.2433-2448

2021

Volltextzugriff (PDF)

Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study

Osteoporosis international, 2021, Vol.32 (1), p.63-73

2021

Volltextzugriff (PDF)

Socio-economic inequalities in fragility fracture outcomes: a systematic review and meta-analysis of prognostic observational studies

Osteoporosis international, 2020, Vol.31 (1), p.31-42

2020

Volltextzugriff (PDF)

The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study

Osteoporosis international, 2021-08, Vol.32 (8), p.1557-1566

2021

Volltextzugriff (PDF)

Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis

Osteoporosis international, 2021, Vol.32 (1), p.173-184

2021

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonists and fracture risk—limitations to current knowledge

Osteoporosis international, 2019-08, Vol.30 (8), p.1709-1710

2019

Volltextzugriff (PDF)

POS0444 DIAGNOSTIC VALUE OF HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY COMPARED TO CONVENTIONAL RADIOGRAPHY FOR DETECTING EROSIVE DISEASE IN RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.451-452

2021

Volltextzugriff (PDF)

Osteogenesis imperfecta and the teeth, eyes, and ears—a study of non-skeletal phenotypes in adults

Osteoporosis international, 2018-12, Vol.29 (12), p.2781-2789

2018

Volltextzugriff (PDF)

Hypercalcemia after discontinuation of long-term denosumab treatment

Osteoporosis international, 2016-07, Vol.27 (7), p.2383-2386

2016

Volltextzugriff (PDF)

1 – 25 von 244

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(235)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A Clinical Guideline on Paget’s Disease of bone—A Guideline or a Review?

SP0037 What To Do When A Fracture Occurs after 3 Years Treatment with An Oral Bisphosphonate?

Is There a Place for Bone Turnover Markers in the Management of Osteoporosis?

The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial

Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study

A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

Romosozumab for the treatment of osteoporosis – a systematic review

Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study

Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis

Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study

Socio-economic inequalities in fragility fracture incidence: a systematic review and meta-analysis of 61 observational studies

Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study

Socio-economic inequalities in fragility fracture outcomes: a systematic review and meta-analysis of prognostic observational studies

The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study

Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis

Glucagon-like peptide-1 receptor agonists and fracture risk—limitations to current knowledge

POS0444 DIAGNOSTIC VALUE OF HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY COMPARED TO CONVENTIONAL RADIOGRAPHY FOR DETECTING EROSIVE DISEASE IN RHEUMATOID ARTHRITIS

Osteogenesis imperfecta and the teeth, eyes, and ears—a study of non-skeletal phenotypes in adults

Hypercalcemia after discontinuation of long-term denosumab treatment

Suchergebnisse filtern